1. BACKGROUND {#s0005}
=============

Heart and lung transplantation has become the standard of care for many eligible patients with end-stage cardiac and pulmonary disease \[[@bb0005],[@bb0010]\]. Transplantation rates are now mainly limited by the availability of suitable donor organs. Long-term outcomes have improved as centers have accumulated expertise in managing immediate postoperative complications of transplantation as well as the long-term sequela of chronic rejection with the improved immunosuppression \[[@bb0005]\].

Heart and lung transplant recipients will often need extra surgical procedures. The morbidity and mortality of common general surgery procedures such as appendectomy, cholecystectomy, hernia repair, and colon and small bowel resection in this patient population are not well known. Lung and heart transplant patients may travel to select centers for transplantation but might require general surgery in their more immediate hospitals. As studies have been limited to case series from select centers \[[@bb0015],[@bb0020]\], we sought to better characterize the outcomes of heart and lung transplant patients who undergo general surgery by examining a national database.

2. METHODS {#s0010}
==========

2.1. Data Source {#s0015}
----------------

The Nationwide Inpatient Sample (NIS) database is currently the largest database of all-payer inpatient data \[[@bb0025]\]. The database is a stratified sample of approximately 20% of US hospitals and contains information on more than 8 million hospital stays per year. This large sample size represents roughly 95% of all hospital discharges and enables analysis of specific patient populations \[[@bb0025]\].

NIS obtains inpatient data from hospital discharge abstracts and billing records and is able to provide patient demographics, hospital length of stay (LOS), morbidity, in-hospital mortality, and inpatient diagnosis and procedure codes using the *International Classification of Diseases, Ninth Revision, Clinical Modification* (*ICD-9-CM*). The database also provides sampling weights that allow calculation of national estimates. Approval for the use of the NIS data in this study was obtained from the Healthcare Cost and Utilization Project (HCUP) \[[@bb0025]\].

2.2. Study Population {#s0020}
---------------------

Using the NIS database from 1998 through 2015 Q3 (NIS transitioned from *ICD-9* to *ICD-10* in Q3), all inpatient hospital encounters for patients undergoing a general surgery procedure, regardless of transplant status, were extracted \[[@bb0025]\]. These encounters were then stratified by transplant status into "transplant" (heart or lung transplant) and "nontransplant" cohorts. Admissions under the age of 18 years, with incomplete data, those who had a cardiac assist device, both a heart and lung transplant, or who underwent a transplant procedure during the admission were excluded from analysis. Additionally, if during analysis a sampling stratum contained only 1 sampling unit, it was excluded. A CONSORT diagram demonstrates how the study population was derived ([Fig 1](#f0005){ref-type="fig"}).Fig 1CONSORT flow diagram for patient selection.Fig 1

Diagnosis and procedural codes were selected using the *ICD-9-CM*. Transplant status was identified using diagnosis codes V42.1 (heart transplant) and V42.6 (lung transplant). Procedures considered "general surgery procedures" included appendectomies, cholecystectomies, inguinal hernia repairs, small bowel resections, and large bowel resections. For a comparator group, patient admissions for the same procedures in a nontransplant group (excludes all solid organ transplant including heart, lung, kidney, liver, small bowel) were also identified. Both open and laparoscopic procedures were included except for inguinal hernia repairs, which included only open procedures. [Appendix A](#s0095){ref-type="sec"} lists all *ICD-9-CM* codes used.

2.3. Outcome Variables {#s0025}
----------------------

Patient demographics extracted included age, sex, ethnicity, household income quartile, insurance status, and discharge disposition. Baseline comorbidities were identified using the Elixhauser classification system \[[@bb0030]\]. Primary outcome measures included the postsurgical mortality, postsurgical morbidity, and hospital length of stay for nontransplant, heart transplant, and lung transplant patients undergoing the same procedures. We performed pairwise comparisons between the nontransplant cohort and either the heart or lung transplant cohort. *Postsurgical mortality* was defined as a patient who died after surgery but before being discharged from the hospital because the NIS database does not include any readmission or postdischarge information. Postsurgical morbidity was defined using select using codes from the *ICD-9-CM* and categorized as either a cardiac, pulmonary, operative, or infectious complication. Secondary outcomes were length of time in days between admission and surgery and whether a *delay*, defined as time greater than median time from admission to surgery, was associated with increased morbidity or mortality.

2.4. Statistical Analysis {#s0030}
-------------------------

Analyses were performed with raw numbers and weighted by sampling hospitals and strata to reflect national averages \[[@bb0035]\]. Binary and categorical variables were compared using the likelihood-ratio test statistic for proportions, which was corrected for survey design using the second-order Rao and Scott correction \[[@bb0040]\]. Continuous variables were compared using 2-sample *t* tests with unequal variance. A multivariate logistic regression with multiple comparisons correction was used to derive factors and their relative weight on postsurgical mortality. Independent variables used for risk adjustment included demographics (age, sex, and ethnicity), hospital size, and Elixhauser comorbidities.

Categorical variables are reported as weighted counts and percentages, whereas continuous variables are reported as ranges or means/medians. Per NIS guidelines, values that contain counts of 10 or fewer were omitted \[[@bb0025]\]. A *P* value of \< .05 was considered statistically significant. All reported *P* values are 2-sided.

Statistical analysis of categorical variables was performed using *χ*^2^ tests, and cohort comparison was performed using *t* tests and analysis of variance. All data analyses were performed using STATA v.14 (College Station, TX) \[[@bb0045]\].

3. RESULTS {#s0035}
==========

3.1. Demographics and Frequency of Procedures {#s0040}
---------------------------------------------

A total of 313,770 hospital encounters with existing transplants were identified spanning from 1998 to 2015, 222,264 admissions with an existing heart transplant and 91,507 with an existing lung transplant. From the original sample, 9448 admissions were identified having undergone a general surgery procedure, 6433 heart transplant admissions, and 3015 lung transplant admissions. We also identified 23,764,164 patient admissions for the same procedures in a nontransplant group for comparison.

Heart and lung transplant admission demographics differed significantly from the majority of nontransplant admissions demographics ([Table 1](#t0005){ref-type="table"}). Transplant patients undergoing general surgery procedures were often older (mean age of 57 years transplant vs 51 years nontransplant) and of male sex (68% transplant vs 40% nontransplant). They were also primarily white (81% vs 70% nontransplant), and a majority were Medicare recipients (58% vs 31% nontransplant).Table 1Demographics by heart and lung transplant status undergoing procedures to those without[⁎](#tf0005){ref-type="table-fn"}Table 1NontransplantHeart TransplantLung Transplant*N* = 23,764,164*N* = 6397*PN* = 2990*P***Age, y**\< .001\< .00118--448,274,19935%73111%64922%45--647,698,03832%312749%156852%65--846,715,84528%251539%77326%85 +\
**Sex**1,047,4414%200%\
\< .00100%\
\< .001Male9,032,67438%484476%150550%Female14,654,18962%153824%148550%**Race**\< .001White13,670,53458%430967%212171%African American2,100,0739%4928%1375%Hispanic2,360,56410%2975%1023%Other\
**Primary payer**1,104,1035%1803%\
\< .001502%\
.002Medicare7,962,63734%391961%156952%Medicaid2,462,75610%3485%1997%Private insurance10,888,34046%194830%115939%Self-pay1,471,1606%290%191%No charge148,3211%150%00%Other\
**Income quartile for ZIP code**770,4323%1392%\
.195421%\
.042First quartile4,623,49419%110517%48416%Second quartile6,011,82325%162525%67423%Third quartile6,028,94725%159525%80427%Fourth quartile6,569,34428%196531%98833%**Hospital region**.503.378Northeast4,587,01319%128520%55919%Midwest5,156,49622%161125%85128%South9,056,75838%215034%100234%West\
**Elective admission**4,963,89721%135121%\
.09857719%\
.311Nonelective surgery14,090,10259%362757%172558%Elective surgery9,000,79538%258940%120640%[^1]

General surgery procedures remained relatively constant for heart transplant patients from 1998 to 2015 but steadily increased for lung transplant patients ([Fig 2](#f0010){ref-type="fig"}). The majority of both heart and lung transplant patients underwent general surgery procedures as nonelective cases (57% and 58%, respectively). The most common general surgery procedures in heart and lung transplant patients were cholecystectomy (38%, 38%), colorectal resection (19%, 25%), and lysis of peritoneal adhesions (11%, 14%) ([Table 2](#t0010){ref-type="table"}). While admitted in the hospital, heart and lung transplant patients undergoing general surgery procedures had more than 1 procedure compared to the nontransplant group.Fig 2Number of heart and lung transplant patients undergoing elective procedures per year (1998--2015).Fig 2Table 2Specific general surgery procedures performed and overall outcomes[⁎](#tf0010){ref-type="table-fn"}Table 2NontransplantHeart TransplantLung Transplant*N* = 23,764,164*N* = 6397*PN* = 2990*P***Number of procedures**\< .001\< .00116,833,68129%133221%62021%25,766,44124%144423%64422%3--56,605,77728%178028%88229%5--103,997,86817%155824%73124%10 or more560,3962%2844%1124%**Procedure type**Inguinal/femoral hernia repair717,8733%6039%\< .001682%.290Cholecystectomy7,342,58031%241538%\< .001112238%.002Appendectomy4,586,87919%5368%\< .00132511%\< .001Small bowel resection1,221,5425%4307%.0151816%.305Colorectal resection4,506,49419%120719%.92475525%\< .001Laparoscopy (GI only)479,7052%1873%.028702%.562Exploratory laparotomy929,5384%2915%.307592%.011Lysis of peritoneal adhesions3,979,55317%73011%\< .00141014%.058**Length of stay, d**\< .0017 or more6,909,26929%263741%128243%30 or more\
**Median length of stay**494,967\
4 days2%366\
6 days6%\
\< .001141\
6 days5%\
\< .001**Disposition of patient**\< .001\< .001Routine19,033,47880%462272%210670%Transfer to short-term hospital161,5731%1132%682%Transfer to different facility1,895,6158%5168%1836%Home health care2,082,2349%87914%49617%Against medical advice34,0780%150%00%Expired544,8112%2484%\< .0011375%\< .001[^2]

3.2. Outcomes of Specific Procedures {#s0045}
------------------------------------

Although most patients were discharged home after surgery, transplant patients had lower rates than nontransplant patients ([Table 2](#t0010){ref-type="table"}). Mortality rates were higher in the heart and lung transplant patients compared to the nontransplant group (4% vs 2%, *P* \< .001 and 5% vs 2%, *P* \< .001 mortality, respectively). Overall complication rates for all general surgeries had greater variability. Heart transplants had the lower rate of total complications, whereas lung transplants had the highest (9% heart transplant, 13% lung transplant, 11% nontransplant). Disparities also existed between the groups for length of stay. Transplant patients were more likely to have longer median LOS in the hospital (6 days for both heart and lung transplant patients) versus nontransplant patients (4 days, *P* \< .0001, [Table 2](#t0010){ref-type="table"}). There were also more heart and lung transplant patients who had prolonged length of stay of 30 days or more than nontransplant patients.

Examining specific surgical procedures, small bowel resections had the highest complication rates overall (\> 45%) for both transplant and nontransplant patients ([Table 3](#t0015){ref-type="table"}). Transplant patients who had either a cholecystectomy or appendectomy also had higher complication rates. Pulmonary and cardiac specific complications were significantly higher in heart and lung transplant patients versus nontransplant patients in those patients undergoing cholecystectomy, appendectomy, and colorectal resection. Heart transplant patients who had an appendectomy had a 3% operative mortality compared to 1% for nontransplant patients, *P* = .002. Transplant and nontransplant patients had a similar complication profile after hernia repair, with heart transplant patients having fewer cardiac complications than nontransplant patients (6% vs 15%, *P* = .003). Compared to nontransplant and heart transplant patients, lung transplant patients had significantly higher complications (cardiac, pulmonary, and infectious) as well as prolonged length of stay after a lysis of adhesions procedure ([Table 3](#t0015){ref-type="table"}).Table 3Outcomes for specific general surgery proceduresTable 3NontransplantHeart Transplant*P*Lung Transplant*P*[**Inguinal/femoral hernia repair**]{.ul}**Any complication**180,59825%11419%.0942029%.734Cardiac complications110,40215%346%.0031116%.976Pulmonary complications50,7527%386%.711[⁎](#tf0015){ref-type="table-fn"}Operative complications13,2062%102%.83600%.634Infectious complications46,3916%529%.300[⁎](#tf0015){ref-type="table-fn"}Expired\
Median LOS13,522\
3 d2%[⁎](#tf0015){ref-type="table-fn"}\
3 d\
.731[⁎](#tf0015){ref-type="table-fn"}\
3 d\
.302  [**Cholecystectomy**]{.ul}**Any complication**1,473,29120%65127%\< .00129026%.039Cardiac complications585,7198%2018%.79613912%.017Pulmonary complications502,2527%29712%\< .00110810%.118Operative complications170,6952%954%.015283%.815Infectious complications571,7228%24010%.062797%.763Expired87,1731%422%.220101%.749Median LOS3 d4 d\< .0015 d\< .001  [**Appendectomy**]{.ul}**Any complication**552,75212%14627%\< .00110231%\< .001Cardiac complications154,9313%336%.098206%.205Pulmonary complications208,6685%7514%\< .0014815%\< .001Operative complications70,1002%[⁎](#tf0015){ref-type="table-fn"}155%.040Infectious complications236,1225%6913%\< .0013310%.061Expired23,3271%143%.00200%.578Median LOS2 d5 d\< .0015 d\< .001  [**Small bowel resection**]{.ul}**Any complication**568,53247%19746%.8918446%.974Cardiac complications96,0708%4210%.1373519%.612Pulmonary complications228,67119%8219%.9383017%.748Intraoperative complications113,3509%327%.540158%.814Infectious complications282,28123%9723%.9163017%.357Expired103,9359%5312%.2122514%.260Median LOS9 d10 d.86710 d.953  [**Colorectal resection**]{.ul}**Any complication**1,446,93432%41935%.36032543%.001Cardiac complications601,63513%12510%.16815721%.007Pulmonary complications552,33512%21117%.01211816%.204Intraoperative complications190,9834%585%.694304%.840Infectious complications591,07813%18215%.34814419%.032Expired182,6594%766%.061679%.001Median LOS7 d9 d\< .0019 d.015  [**Laparoscopy (GI only)**]{.ul}**Any complication**163,10434%9551%.0133854%.105Cardiac complications55,97812%105%.2181014%.814Pulmonary complications70,95815%4826%.0761420%.533Intraoperative complications25,1925%105%.964[⁎](#tf0015){ref-type="table-fn"}Infectious complications67,59114%5328%.0072435%.033Expired69,01414%3418%.5561521%.444Median LOS6 d9 d.00110 d.386  [**Exploratory laparotomy**]{.ul}**Any complication**144,93016%5218%.6592034%.059Cardiac complications42,7815%186%.5311017%.027Pulmonary complications49,8975%[⁎](#tf0015){ref-type="table-fn"}1017%.085Intraoperative complications37,1164%00%.20600%.507Infectious complications46,7345%3311%.027[⁎](#tf0015){ref-type="table-fn"}Expired92321%[⁎](#tf0015){ref-type="table-fn"}00%.745Median LOS2 d4 d.0016 d.112  [**Lysis of peritoneal adhesions**]{.ul}**Any complication**815,34420%19627%.05714736%.001Cardiac complications234,1726%7210%.0425012%.022Pulmonary complications296,9787%7510%.2026315%.004Intraoperative complications223,9876%284%.312154%.417Infectious complications285,3797%7210%.1855714%.014Expired58,1711%142%.680143%.127Median LOS3 d7 d\< .0016 d\< .001[^3]

3.3. Correlation Between Time From Admission to Operative Procedure and Predictors of Mortality {#s0050}
-----------------------------------------------------------------------------------------------

We determined the median time from admission to surgery for 4 select procedures for nontransplant patients, heart, and lung transplant patients (median time nontransplant, heart transplant, lung transplant), respectively: cholecystectomy (1, 1, 1 day), appendectomy (0, 0, 0 day), small bowel resection (1, 1, 1 day), and colorectal resection (0, 1, 0 day). *Delay in surgery* was defined as a surgery that occurred after the median time to surgery for that specific procedure. As shown in [Table 4](#t0020){ref-type="table"}, mortality was only increased in patients undergoing small bowel resection whose surgery was delayed greater than the median time determined. Multivariable logistic regression using comorbidities, age, hospital size, and transplant status revealed that hospital size and comorbidities were predictors of mortality for patients undergoing cholecystectomy, appendectomy, small bowel resection, and colorectal resection. Transplant status was not found to be a predictor ([Table 5](#t0025){ref-type="table"}).Table 4Correlation of delay in surgery with outcomesTable 4Total CasesMortalityMortality %*P***Cholecystectomy**No transplant2,227,76023,0261.03%Heart821192.31%.097Lung37500.00%.443**Appendectomy**No transplant588,62319310.33%-Heart7900.00%.830Lung4400.00%.865**Small bowel resection**No transplant281,08827,7089.86%Heart1033433.01%**.000**Lung411639.02%**.008Colorectal resection**\
No transplant\
1,359,171\
97,439\
7.17%Heart3704311.62%.258Lung2973511.78%.957Table 5Multivariable predictors of mortalityTable 5PredictorsOdds Ratio95% CITransplant Status0.980.69--1.39Age1.051.05--1.05Race1.000.99--1.01Female sex0.850.84--0.87Hospital bed status1.121.09--1.15Congestive heart failure2.092.05--2.14Chronic lung condition1.271.24--1.30Coagulopathy4.063.95--4.17Diabetes0.910.86--0.95Hypertension0.420.41--0.43Liver disease2.562.49--2.63Electrolyte abnormalities2.922.85--2.98Obese0.550.53--0.57Peripheral vascular disease2.172.11--2.23Pulmonary circulation disorders1.531.46--1.60Renal failure1.771.70--1.84Weight loss1.741.69--1.79

4. DISCUSSION {#s0055}
=============

Improved immunosuppressive medications and continued experience in transplantation have resulted in heart and lung transplant recipients living longer. With improved survival, heart and lung transplant patients are at higher risk of being inflicted with conditions that require general surgery \[[@bb0050],[@bb0055]\]. Although the index general surgery operation may not necessarily differ between immunocompetent and immunocompromised patients, the ability of transplant patients to recover from complications is limited. Smith et al showed that, in lung transplant patients requiring abdominal surgery, time to surgery of longer than 6 days appeared to be associated with mortality \[[@bb0060]\]. Our goal was to find guidance on whether these patients should be transferred to tertiary care facilities for their general surgical care or if their acute issues could be dealt locally, avoiding unnecessary travel and delay in treatment. Our study is the first to use a population-based analysis to determine outcomes after such procedures. Our findings are more generalizable than those of previous case series that only report findings from select centers.

4.1. Major Findings {#s0060}
-------------------

We found that heart and lung transplant patients constitute an older subgroup of general surgical patients. These patients also undergo more than 1 procedure while admitted and often have a prolonged length of stay, consistent with transplant patients having more comorbidities \[[@bb0065]\]. Our study shows that some procedures such an inguinal/femoral hernia repair can by performed safely in either population. For small bowel resections, the outcomes are similar in transplant and nontransplant populations unless there is a delay to surgery. Prior studies have demonstrated that conditions warranting small bowel resection are complex and carry excess morbidity whether or not immunosuppression and transplantation are involved \[[@bb0070]\]. Results from our study show that for other procedures such as appendectomies, cholecystectomies and abdominal exploration, there is considerable morbidity in heart and lung transplant patients.

Higher morbidity and greater number of operations required for similar diagnosis suggest the higher complexity of similar abdominal problems in thoracic transplant patients. This may not necessarily be a function of their prevalent level of immunosuppression but more likely is a function of cumulative effect of immunosuppression over the lifetime of the transplant. Managing the same disease process in a transplant patient may require one to lean toward being more conservative and choose early operative intervention as opposed to percutaneous temporization interventions. Similarly, intraoperatively, in our practice, we have noticed that surgeons take a more conservative approach in transplant patients, such as use of nonabsorbable sutures for fascial closure and greater use of alimentary tract diversion rather than primarily reestablishing continuity. Prior experience in managing this patient group could be invaluable when facing such a presentation.

4.2. Limitations and Strengths {#s0065}
------------------------------

We recognize that there are several limitations to our retrospective data set analysis. Our study is limited to only short-term inpatient outcomes, and postdischarge outcomes such as readmission are not known. The study encompasses 17 years, in which practices may have changed. Because of the small sample size, it was not possible to examine the impact of minimally invasive surgical techniques or volume outcome relationships. Additional factors, such as the specialty training and board certification of the operating surgeon, are not known within the NIS data set, which may be an important determinant of quality of care. We also found that transplant status was not an independent predictor of outcome. We feel that transplant status is a surrogate for comorbidities which are more prevalent in transplant patients. Hence, this may be a construct of our statistical analysis and be a predictor in other models where as many comorbidities are not included. Another limitation is that we are unable to identify when the transplantation occurred, therefore rendering it more difficult when factoring in comorbidities and immunosuppression. Finally, because NIS data are deidentified, hospital admissions rather than individual patients were analyzed. It is therefore possible that a transplant patient may have had more than 1 hospital admission. Given the size of the transplant population (388,118 encounters), NIS\'s sampling strategies, and variability in patient demographics, this is expected to be a rare occurrence and is adjusted for by not reporting on groups with fewer than 10 individuals.

Despite these limitations, our study is the first ever to report a population-based analysis of general surgical outcomes in heart and lung transplant patients with a meaningful sample size. We conclude that all general surgical procedures should not be taken lightly in this population given the increased potential for morbidities and prolonged length of stay.

4.3. Recommendation {#s0070}
-------------------

The postoperative morbidities and prolonged length of stay after some of these procedures argue that these transplant patients are better served at tertiary care centers \[[@bb0075], [@bb0080], [@bb0085]\]. Our analysis hinted at this, as hospital bed size was a predictor of mortality. The ability to rescue from complications is an increasing well-known factor that determines mortality. Larger institutions are likely better equipped to deal with postoperative complications as well as manage immunosuppression regimes. Specialized medical and surgical units dealing with heart and lung transplant patients can facilitate postoperative care as well as ensure that posttransplant protocols are being followed. Transfer to these specialized facilities, in our opinion, should be considered in patients, particularly if patients are stable. Patients requiring emergent operative intervention, such as that for small bowel obstruction, should not, however, be denied surgery because the patients comorbidities' and not transplant status determine outcome.

Appendix A. *ICD-9-CM* codes {#s0095}
============================

Unlabelled TableStudy Population*ICD-9-CM* CodeHeart transplant statusV42.1Lung transplant statusV42.6**Procedure type**Inguinal/femoral hernia repair53.00--53.05, 53.10--53.17, 53.21, 53.29, 53.31, 53.39Cholecystectomy51.21--51.24Appendectomy47.0, 47.01, 47.09, 47.1, 47.11, 47.19Small bowel resection45.61, 45.62, 45.63Colorectal resection17.31--17.39, 45.71--45.79, 45.8--45.83, 48.40--48.49, 48.5--48.59, 48.61--48.69Laparoscopy (GI only)54.21Exploratory laparotomy54.11Lysis of peritoneal adhesions54.51, 54.59**Morbidity*Cardiovascular***Supraventicular arrhythmia427.30, 427.31, 427.32, 427.0Myocardial infarction410.0--410.9, 411.81, 413.0--413.9, 997.1Postoperative stroke997.02Deep venous thrombosis451.1, 451.2, 451.81, 451.9, 453.2, 453.8, 453.9, 453.40--453.42Pulmonary embolism415.1, 415.11, 415.12, 415.19***Pulmonary***Pneumonia481--486, 482.0--482.3, 482.41, 482.49, 482.80, 482.83, 482.9, 486, 997.3, 997.31, 997.32Postoperative acute respiratory insufficiency518.5Postoperative acute pneumothorax512.1Postoperative pulmonary edema518.4Pulmonary collapse518.0Empyema with and without510.0, 510.9FistulaMechanical ventilation96.70, 96.71, 96.72Noninvasive ventilation93.90***Infectious***Sepsis/shock995.91, 038, 995.92, 999.3, 998.0Urinary tract infection599.0, 590.9Postoperative wound infection998.51, 998.59***Intraoperative complication***Accidental puncture or laceration, complicating surgery998.2Bleeding complicating procedure998.11
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